Research progress on the source, production, and anti-cancer mechanisms of paclitaxel.
10.1016/S1875-5364(20)60032-2
- Author:
Yan-Hua YANG
1
;
Jia-Wang MAO
2
;
Xiao-Li TAN
3
Author Information
1. Institute of Life Sciences, Jiangsu University, Zhenjiang 212013, China. Electronic address: yanhuayang@126.com.
2. Institute of Life Sciences, Jiangsu University, Zhenjiang 212013, China.
3. Institute of Life Sciences, Jiangsu University, Zhenjiang 212013, China. Electronic address: xltan@ujs.edu.cn.
- Publication Type:Review
- Keywords:
Anti-cancer mechanisms;
Paclitaxel (Taxol);
Production methods;
Source
- MeSH:
Antineoplastic Agents, Phytogenic/pharmacology*;
Humans;
Neoplasms/drug therapy*;
Paclitaxel/pharmacology*
- From:
Chinese Journal of Natural Medicines (English Ed.)
2020;18(12):890-897
- CountryChina
- Language:English
-
Abstract:
Paclitaxel, a tetracyclic diterpenoid compounds, was firstly isolated from the bark of the Pacific yew trees. Currently, as a low toxicity, high efficiency, and broad-spectrum natural anti-cancer drug, paclitaxel has been widely used against ovarian cancer, breast cancer, uterine cancer, and other cancers. As the matter of fact, natural paclitaxel from Taxus species has been proved to be environmentally unsustainable and economically unfeasible. For this reason, researchers from all over the world are devoted to searching for new ways of obtaining paclitaxel. At present, other methods, including artificial cultivation of Taxus plants, microbial fermentation, chemical synthesis, tissue and cell culture have been sought and developed subsequently. Meanwhile, the biosynthesis of paclitaxel is also an extremely attractive method. Unlike other anti-cancer drugs, paclitaxel has its unique anti-cancer mechanisms. Here, the source, production, and anti-cancer mechanisms of paclitaxel were summarized and reviewed, which can provide theoretical basis and reference for further research on the production, anti-cancer mechanisms and utilization of paclitaxel.
